ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,092 | -99.4% | 4,954 | -99.3% | 0.00% | – |
Q2 2023 | $5,715,755 | -63.5% | 681,258 | -56.8% | 0.00% | -100.0% |
Q1 2023 | $15,665,350 | +133.0% | 1,577,578 | +63.3% | 0.00% | 0.0% |
Q4 2022 | $6,723,889 | +19.9% | 966,076 | -8.0% | 0.00% | 0.0% |
Q3 2022 | $5,609,000 | +108.4% | 1,050,459 | +55.7% | 0.00% | – |
Q2 2022 | $2,692,000 | +15735.3% | 674,584 | +17051.9% | 0.00% | – |
Q1 2022 | $17,000 | – | 3,933 | +3872.7% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 99 | -100.0% | 0.00% | -100.0% |
Q3 2021 | $10,554,000 | -22.5% | 1,202,010 | -0.0% | 0.00% | 0.0% |
Q2 2021 | $13,620,000 | +50.9% | 1,202,096 | +58.2% | 0.00% | 0.0% |
Q1 2021 | $9,026,000 | +924.5% | 759,794 | +491.3% | 0.00% | – |
Q4 2020 | $881,000 | -26.0% | 128,488 | -20.0% | 0.00% | – |
Q3 2020 | $1,190,000 | -53.4% | 160,533 | -73.8% | 0.00% | – |
Q2 2020 | $2,553,000 | -14.4% | 612,133 | -49.3% | 0.00% | – |
Q1 2020 | $2,981,000 | -61.8% | 1,206,733 | -10.1% | 0.00% | -100.0% |
Q4 2019 | $7,795,000 | +10.2% | 1,341,633 | -0.0% | 0.00% | 0.0% |
Q3 2019 | $7,071,000 | -26.0% | 1,341,733 | -15.8% | 0.00% | 0.0% |
Q2 2019 | $9,560,000 | -44.2% | 1,593,333 | -15.9% | 0.00% | -50.0% |
Q1 2019 | $17,118,000 | -19.6% | 1,895,633 | -26.1% | 0.00% | -33.3% |
Q4 2018 | $21,284,000 | -39.9% | 2,564,333 | 0.0% | 0.00% | -25.0% |
Q3 2018 | $35,388,000 | +176.3% | 2,564,333 | +59.1% | 0.00% | +300.0% |
Q2 2018 | $12,810,000 | +6.0% | 1,611,311 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $12,085,000 | +10.3% | 1,611,311 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $10,957,000 | -5.6% | 1,611,311 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $11,601,000 | +49.2% | 1,611,311 | -2.6% | 0.00% | 0.0% |
Q2 2017 | $7,775,000 | -8.8% | 1,654,311 | -3.0% | 0.00% | 0.0% |
Q1 2017 | $8,527,000 | -11.3% | 1,705,311 | -5.1% | 0.00% | 0.0% |
Q4 2016 | $9,618,000 | -31.9% | 1,797,811 | 0.0% | 0.00% | -50.0% |
Q3 2016 | $14,113,000 | +38.0% | 1,797,811 | 0.0% | 0.00% | +100.0% |
Q2 2016 | $10,230,000 | +69.8% | 1,797,811 | +25.0% | 0.00% | 0.0% |
Q1 2016 | $6,024,000 | -38.2% | 1,437,811 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $9,748,000 | +16.3% | 1,437,811 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $8,382,000 | -24.9% | 1,437,811 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $11,157,000 | +28.8% | 1,437,811 | +72.2% | 0.00% | 0.0% |
Q1 2015 | $8,665,000 | +43.8% | 834,811 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $6,027,000 | +20.1% | 834,811 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $5,017,000 | -9.2% | 834,811 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $5,526,000 | – | 834,811 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |